{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:44:52Z","timestamp":1792611892129,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The role of different immune cells in autism spectrum disorders (ASD) is still controversial. The purpose of this study was to evaluate the causal effects of different immune cell phenotypes on ASD via Mendelian randomization (MR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Datasets of immune cell phenotypes were obtained from the European Bioinformatics Institute, and datasets of ASD were obtained from the IEU Open GWAS project. Single nucleotide polymorphisms were selected based on the assumptions of association, independence, and exclusivity. Inverse variance weighted was utilized as the main method for MR analysis. MR-Egger was employed to assess the horizontal pleiotropy of the results. Cochran\u2019s Q and leave-one-out method were used for heterogeneity analysis and sensitivity analysis of the results, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MR analysis showed that TD CD8br AC [odds ratio (OR), 1.137; 95% confidence interval (CI), 1.031\u20131.254; <jats:italic>p<\/jats:italic> = 0.010], CD8br %leukocyte (OR, 1.142; 95% CI, 1.067\u20131.223; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), CD8br and CD8dim %leukocyte (OR, 1.117; 95% CI, 1.032\u20131.210; <jats:italic>p<\/jats:italic> = 0.006), naive CD8br %T cell (OR, 1.052; 95% CI, 1.004\u20131.104; <jats:italic>p<\/jats:italic> = 0.035), CD28\u2212 CD8dim %T cell (OR, 1.097; 95% CI, 1.038\u20131.158; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), CD127\u2212 CD8br AC (OR, 1.086; 95% CI, 1.006\u20131.171; <jats:italic>p<\/jats:italic> = 0.034), CD45 on CD8br (OR, 1.059; 95% CI, 1.021\u20131.099; <jats:italic>p<\/jats:italic> = 0.002), CD3 on HLA DR+ CD8br (OR, 1.098; 95% CI, 1.041\u20131.158; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), CD4 on activated Treg (OR, 1.048; 95% CI, 1.001\u20131.096; <jats:italic>p<\/jats:italic> = 0.046), CD3 on CD39+ resting Treg (OR, 1.070; 95% CI, 1.012\u20131.131; <jats:italic>p<\/jats:italic> = 0.018), IgD+ CD38\u2212 %lymphocyte (OR, 1.103; 95% CI, 1.023\u20131.190; <jats:italic>p<\/jats:italic> = 0.011), CD62L\u2212 plasmacytoid DC %DC (OR, 1.046; 95% CI, 1.001\u20131.093; <jats:italic>p<\/jats:italic> = 0.046), and FSC-A on plasmacytoid DC (OR, 1.075; 95% CI, 1.003\u20131.153; <jats:italic>p<\/jats:italic> = 0.042) were associated with increased genetic susceptibility to ASD. MR-Egger displayed no horizontal pleiotropy (<jats:italic>p<\/jats:italic> \u2265 0.05). Cochran\u2019s Q revealed no heterogeneity of results (<jats:italic>p<\/jats:italic> \u2265 0.05). Sensitivity analysis indicated that the results were robust.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This MR analysis revealed 13 immune cell phenotypes associated with increased genetic susceptibility to ASD and emphasized the importance of CD8 T cells and Tregs, which provides new directions for the pathogenesis and drug research of ASD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1397006","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:46:32Z","timestamp":1715939192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Causal effects of 731 immune cell phenotypes on autism spectrum disorder: a Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Yunfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2020.02.007","article-title":"Autism spectrum disorder: characteristics, associated behaviors, and early intervention","volume":"67","author":"Kodak","year":"2020","journal-title":"Pediatr Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-022-01310-w","article-title":"The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis","volume":"48","author":"Salari","year":"2022","journal-title":"Ital J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23661","article-title":"Autism spectrum disorder: A review","volume":"329","author":"Hirota","year":"2023","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-015-2521-7","article-title":"Brief report: forecasting the economic burden of autism in 2015 and 2025 in the United States","volume":"45","author":"Leigh","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v13.i6.262","article-title":"Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials","volume":"13","author":"Hellings","year":"2023","journal-title":"World J Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2020.04.018","article-title":"Oxidative stress, metabolic and mitochondrial abnormalities associated with autism spectrum disorder","volume":"173","author":"Thorsen","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","article-title":"The immune system, cytokines, and biomarkers in autism spectrum disorder","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci Bull"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21307\/ane-2017-025","article-title":"Immune dysfunction and neuroinflammation in autism spectrum disorder","volume":"76","author":"Bjorklund","year":"2016","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13229-021-00472-4","article-title":"Regulatory T lymphocytes\/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis","volume":"12","author":"Ellul","year":"2021","journal-title":"Mol Autism"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/children8020116","article-title":"Dysregulation of ki-67 expression in T cells of children with autism spectrum disorder","volume":"8","author":"Alhosaini","year":"2021","journal-title":"Children (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1171517","article-title":"Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study","volume":"13","author":"Ren","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1017\/S003329171400172X","article-title":"The epidemiology and global burden of autism spectrum disorders","volume":"45","author":"Baxter","year":"2015","journal-title":"Psychol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2018.05.002","article-title":"Immune aberrations in children with Autism Spectrum Disorder: a case-control study from a tertiary care neuropsychiatric hospital in India","volume":"94","author":"Basheer","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100069","article-title":"Immunity and autoantibodies of a mouse strain with autistic-like behavior","volume":"4","author":"Uddin","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104223","article-title":"Development, phenotypes of immune cells in BTBR T+Itpr3tf\/J mice","volume":"358","author":"Uddin","year":"2020","journal-title":"Cell Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2016-000070","article-title":"Characterization of immune cell phenotypes in adults with autism spectrum disorders","volume":"64","author":"L\u00f3pez-Cacho","year":"2016","journal-title":"J Investig Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5120-4","article-title":"Elevated IL-16 expression is associated with development of immune dysfunction in children with autism","volume":"236","author":"Ahmad","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2018.12.020","article-title":"Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children","volume":"106","author":"Ahmad","year":"2019","journal-title":"Mol Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25610","article-title":"T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains","volume":"86","author":"DiStasio","year":"2019","journal-title":"Ann Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1997.68","article-title":"The role of CD45 and CD45-associated molecules in T cell activation","volume":"75","author":"Altin","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206927","article-title":"Protein tyrosine phosphatase receptor type C (PTPRC or CD45)","volume":"74","author":"Al Barashdi","year":"2021","journal-title":"J Clin Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106466","article-title":"Involvement of CD45 cells in the development of autism spectrum disorder through dysregulation of granulocyte-macrophage colony-stimulating factor, key inflammatory cytokines, and transcription factors","volume":"83","author":"Ahmad","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B28","article-title":"[Structure and function of lymphocyte TCR\/CD3 complex]","volume":"57","author":"Bo\u0107ko","year":"2003","journal-title":"Postepy Hig Med Dosw"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3RU0420-668RR","article-title":"HLA-DR-expressing NK cells: Effective killers suspected for antigen presentation","volume":"109","author":"Erokhina","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.10.027","article-title":"Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism","volume":"65","author":"Ahmad","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","article-title":"CD4+T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00727","article-title":"What else can CD39 tell us","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2684","article-title":"CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells","volume":"78","author":"Canale","year":"2018","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107055","article-title":"Implications of CD39 in immune-related diseases","volume":"89","author":"Zeng","year":"2020","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1397006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:46:36Z","timestamp":1715939196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1397006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":34,"alternative-id":["10.3389\/fpsyt.2024.1397006"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1397006","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"article-number":"1397006"}}